Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder
NCT05562973
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
The principal investigator will be at a new institution.
Conditions
Post-Traumatic Stress Disorder
Interventions
DRUG:
Psilocybin
Sponsor
Johns Hopkins University